Launay, Jean-Marie

CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands

Lamas, B., Richard, M. L., Leducq, V., Pham, H.-P., Michel, M.-L., Da Costa, G., Bridonneau, C., Jegou, S., Hoffmann, T. W., Natividad, J. M., et al. (2016) · Nature Medicine

Gut microbiota and healthInflammatory Bowel Disease

Cited by 1,482

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease

Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 1,172

Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome

Natividad, J. M., Agus, A., Planchais, J., Lamas, B., Jarry, A. C., Martin, R., Michel, M.-L., Chong-Nguyen, C., Roussel, R., Straube, M., et al. (2018) · Cell Metabolism

Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases

Cited by 642

Abnormal melatonin synthesis in autism spectrum disorders

Melke, J., Goubran Botros, H., Chaste, P., Betancur, C., Nygren, G., Anckarsäter, H., Rastam, M., Ståhlberg, O., Gillberg, I. C., Delorme, R., et al. (2008) · Molecular Psychiatry

Circadian rhythm and melatoninAutism Spectrum Disorder Research

Cited by 511

MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants

Baudry, A., Mouillet-Richard, S., Schneider, B., Launay, J.-M., & Kellermann, O. (2010) · Science

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 480

Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations

Bodemer, C., Hermine, O., Palmérini, F., Yang, Y., Grandpeix-Guyodo, C., Leventhal, P. S., Hadj-Rabia, S., Nasca, L., Georgin-Lavialle, S., Cohen-Akenine, A., et al. (2010) · Journal of Investigative Dermatology

Mast cells and histamineGastrointestinal Tumor Research and Treatment

Cited by 397

Maternal serotonin is crucial for murine embryonic development

Côté, F., Fligny, C., Bayard, E., Launay, J.-M., Gershon, M. D., Mallet, J., & Vodjdani, G. (2007) · Proceedings of the National Academy of Sciences

Neurotransmitter Receptor Influence on BehaviorNeurogenesis and neuroplasticity mechanisms

Cited by 381

Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives

Leboyer, M., Philippe, A., Bouvard, M., Guilloud-Bataille, M., Bondoux, D., Tabuteau, F., Feingold, J., Mouren-Simeoni, M.-C., & Launay, J.-M. (1999) · Biological Psychiatry

Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental Disorders

Cited by 194

The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders

Pagan, C., Delorme, R., Callebert, J., Goubran-Botros, H., Amsellem, F., Drouot, X., Boudebesse, C., Le Dudal, K., Ngo-Nguyen, N., Laouamri, H., et al. (2014) · Translational Psychiatry

Autism Spectrum Disorder ResearchCircadian rhythm and melatonin

Cited by 165

Perinatal undernutrition affects the methylation and expression of the leptin gene in adults: implication for the understanding of metabolic syndrome

Jousse, C., Parry, L., Lambert‐Langlais, S., Maurin, A., Averous, J., Bruhat, A., Carraro, V., Tost, J., Letteron, P., Chen, P., et al. (2011) · The FASEB Journal

Birth, Development, and HealthEpigenetics and DNA Methylation

Cited by 139

Brief report: A double-blind study of naltrexone in infantile autism

Leboyer, M., Bouvard, M. P., Launay, J.-M., Tabuteau, F., Waller, D., Dugas, M., Kerdelhue, B., Lensing, P., & Panksepp, J. (1992) · Journal of Autism and Developmental Disorders

Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental Disorders

Cited by 130

Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: A double-blind, placebo-controlled study

Bouvard, M. P., Leboyer, M., Launay, J.-M., Recasens, C., Plumet, M.-H., Waller-Perotte, D., Tabuteau, F., Bondoux, D., Dugas, M., Lensing, P., et al. (1995) · Psychiatry Research

Autism Spectrum Disorder ResearchNeuroendocrine regulation and behavior

Cited by 112

Microglial production of quinolinic acid as a target and a biomarker of the antidepressant effect of ketamine

Verdonk, F., Petit, A.-C., Abdel-Ahad, P., Vinckier, F., Jouvion, G., de Maricourt, P., De Medeiros, G. F., Danckaert, A., Van Steenwinckel, J., Blatzer, M., et al. (2019) · Brain, Behavior, and Immunity

Tryptophan and brain disordersTreatment of Major Depression

Cited by 99

The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer

Le Corre, D., Ghazi, A., Balogoun, R., Pilati, C., Aparicio, T., Martin-Lannerée, S., Marisa, L., Djouadi, F., Poindessous, V., Crozet, C., et al. (2019) · eBioMedicine

Cancer Cells and MetastasisColorectal Cancer Treatments and Studies

Cited by 48

Prognostic value of the PrP C -ILK-IDO1 axis in the mesenchymal colorectal cancer subtype

Ghazi, A., Le Corre, D., Pilati, C., Taieb, J., Aparicio, T., Didelot, A., Dedhar, S., Mulot, C., Le Malicot, K., Djouadi, F., et al. (2021) · OncoImmunology

Colorectal Cancer Treatments and StudiesCancer Cells and Metastasis

Cited by 21

A proof of concept for targeting the PrPC - Amyloid β peptide interaction in basal prostate cancer and mesenchymal colon cancer

Mouillet-Richard, S., Martin-Lannerée, S., Le Corre, D., Hirsch, T. Z., Ghazi, A., Sroussi, M., Pilati, C., de Reyniès, A., Djouadi, F., Vodovar, N., et al. (2022) · Oncogene

Prion Diseases and Protein MisfoldingAlzheimer's disease research and treatments

Cited by 14